FTC Nominee Khan Is Likely To Face Close Senate Vote; Biden Still Has One More Seat To Fill
Executive Summary
Columbia’s Khan is known for her critical views of tech industry, which observers expect will transfer to pharma; another possible nominee for the other remaining spot, DC attorney general Karl Racine, is also focused on the tech space. Acting Chair Rebecca Kelly Slaughter’s pharma interest likely means the issue won’t recede from the FTC’s agenda.